Multiple myeloma has seen many advances in recent years, and novel targeted agents are transforming the field. Several immunotherapies, including...

An insight into novel targets in myeloma and mechanisms of resistance to PIs and IMiDs

The Video Journal of Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review!  For more news visit www.vjhemonc.com

Medicine

Health & Fitness

The Video Journal of Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjhemonc.com

Share An insight into novel targets in myeloma and mechanisms of resistance to PIs and IMiDs

Sign up to save your podcasts

An insight into novel targets in myeloma and mechanisms of resistance to PIs and IMiDs

An insight into novel targets in myeloma and mechanisms of resistance to PIs and IMiDs